Page last updated: 2024-08-26

mizoribine and Bright Disease

mizoribine has been researched along with Bright Disease in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19904 (21.05)18.7374
1990's3 (15.79)18.2507
2000's4 (21.05)29.6817
2010's8 (42.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manabe, S; Nagata, M; Nitta, K1
Mii, A; Shimizu, A; Takada, D; Tsuruoka, S1
Iwamura, C; Kameoka, Y; Kobayashi, S; Kusunoki, R; Nagao, T; Nakayama, T; Suzuki, K; Yumura, W1
Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y1
Fujio, K; Kanda, H; Kubo, K; Sakurai, K; Yamamoto, K1
Abe, Y; Fuke, T; Hisano, M; Itabashi, K; Mikawa, T; Tsuji, Y; Watanabe, S1
Arimura, Y; Kawashima, S; Yoshihara, K1
Guo, HB1
Chinda, J; Fujino, T; Hasebe, N; Kabara, M; Matsuki, M; Nakagawa, N1
Fujita, T; Murakami, R; Nakamura, N; Shimada, M; Shimaya, Y; Yamabe, H1
Hashimoto, Y; Hirayama, A; Hirayama, K; Kobayashi, M; Koyama, A; Nagase, S; Nagata, M; Shimizu, Y; Usui, J; Yamagata, K; Yoh, K1
Kobayashi, Y; Masaki, Y; Shigematsu, H1
Kamata, K; Kobayashi, Y; Masaki, Y; Okubo, M; Tanaka, T; Uchiyama, T1
Ito, M; Okamoto, K; Suzuki, Y1
Endo, T; Horata-Takahashi, E; Kamata, K; Kobayashi, Y; Kumano, K; Nakayama, Y; Okubo, M; Osakabe, T; Sato, K; Tamura, K1
Hosono, S; Kato, K; Murakami, R; Muramatsu, M; Omote, A; Sano, H; Sugimoto, Y; Tanaka, H; Watanabe, Y1
Abe, M; Shimizu, M; Shou, I; Tomino, Y; Tsuge, T1
Akimoto, T; Ando, Y; Asano, Y; Ito, C; Kusano, E1
Aozuka, S; Chen, XM; Kobayashi, Y1

Reviews

3 review(s) available for mizoribine and Bright Disease

ArticleYear
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Contributions to nephrology, 2018, Volume: 195

    Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases

2018
[ANCA associated vasculitis and PRGN].
    Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:2

    Topics: Animals; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Cyclophosphamide; Disease Progression; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Recurrence; Ribonucleosides; Vasculitis

2009
Mesangial immunoglobulin A deposition and focal glomerulosclerosis in a renal transplant patient with nephrotic syndrome--Berger's disease alone or superimposition of focal glomerulosclerosis?
    Transplantation proceedings, 1993, Volume: 25, Issue:2

    Topics: Cyclosporine; Diagnosis, Differential; Female; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Immunoglobulin A; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Nephrotic Syndrome; Prednisolone; Ribonucleosides

1993

Trials

1 trial(s) available for mizoribine and Bright Disease

ArticleYear
Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2004, Volume: 44, Issue:1

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Female; Glomerulonephritis; Humans; Male; Middle Aged; Pilot Projects; Purines; Renal Circulation; Ribonucleosides; Treatment Outcome; Vasculitis

2004

Other Studies

15 other study(ies) available for mizoribine and Bright Disease

ArticleYear
Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.
    CEN case reports, 2018, Volume: 7, Issue:2

    Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin kappa-Chains; Immunosuppressive Agents; Kidney Glomerulus; Prednisolone; Proteinuria; Ribonucleosides; Treatment Outcome

2018
Correlation of interleukin-6 and monocyte chemotactic protein-1 concentrations with crescent formation and myeloperoxidase-specific anti-neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti-interleukin-6 receptor antibody or mizorib
    Microbiology and immunology, 2013, Volume: 57, Issue:9

    Topics: Animals; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Chemokine CCL2; Disease Models, Animal; Female; Glomerulonephritis; Humans; Interleukin-6; Mice; Mice, Inbred C57BL; Peroxidase; Receptors, Interleukin-6; Ribonucleosides; T-Lymphocyte Subsets

2013
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Clinical and experimental nephrology, 2015, Volume: 19, Issue:3

    Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome

2015
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide-resistant ANCA-associated glomerulonephritis.
    International journal of rheumatic diseases, 2017, Volume: 20, Issue:12

    Topics: Antibodies, Antineutrophil Cytoplasmic; Biopsy; Cyclophosphamide; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Microscopic Polyangiitis; Middle Aged; Ribonucleosides; Tacrolimus; Treatment Outcome

2017
Pharmacokinetic study of mizoribine in child-onset glomerulonephritis.
    Pediatrics international : official journal of the Japan Pediatric Society, 2008, Volume: 50, Issue:5

    Topics: Adolescent; Area Under Curve; Child; Child, Preschool; Female; Glomerulonephritis; Half-Life; Humans; Immunosuppressive Agents; Male; Ribonucleosides

2008
Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature.
    Transplantation proceedings, 2010, Volume: 42, Issue:7

    Topics: Acute Kidney Injury; Adult; Allopurinol; Cyclosporine; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prednisone; Renal Dialysis; Ribonucleosides; Sodium Bicarbonate; Transplantation, Homologous

2010
Mizoribine for crescentic glomerulonephritis with sarcoidosis: effectiveness not only for urinalysis abnormalities but also for hilar lymph node enlargement.
    Modern rheumatology, 2013, Volume: 23, Issue:1

    Topics: Antibodies, Antineutrophil Cytoplasmic; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Function Tests; Lymph Nodes; Lymphatic Diseases; Middle Aged; Peroxidase; Prednisolone; Radiography, Thoracic; Ribonucleosides; Sarcoidosis; Treatment Outcome; Urinalysis

2013
Mizoribine suppresses proliferation of rat glomerular epithelial cells in culture and inhibits increase of monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 stimulated by thrombin.
    Biological & pharmaceutical bulletin, 2012, Volume: 35, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Cattle; Cell Proliferation; Chemokine CCL2; Chemokine CXCL2; Dose-Response Relationship, Drug; Epithelial Cells; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides; RNA, Messenger; Thrombin

2012
Modification of crescentic Masugi nephritis in the rabbit by Bredinin, a new immunosuppressant.
    Virchows Archiv. B, Cell pathology including molecular pathology, 1983, Volume: 43, Issue:2

    Topics: Animals; Antibody Formation; Creatinine; Glomerulonephritis; Kidney Glomerulus; Proteinuria; Rabbits; Ribonucleosides; Time Factors

1983
Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice.
    Clinical immunology and immunopathology, 1984, Volume: 33, Issue:1

    Topics: Animals; Body Weight; Glomerulonephritis; Kidney; Kidney Function Tests; Life Expectancy; Lupus Erythematosus, Systemic; Mice; Mice, Inbred NZB; Organ Size; Ribonucleosides; Spleen

1984
Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine. (2) Effect on crescentic-type anti-GBM nephritis in rats.
    Japanese journal of pharmacology, 1984, Volume: 34, Issue:1

    Topics: Animals; Autoimmune Diseases; Azathioprine; Basement Membrane; Glomerulonephritis; Immunosuppressive Agents; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Ribonucleosides

1984
Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Acute Kidney Injury; Antibodies, Antineutrophil Cytoplasmic; Anticoagulants; Autoimmune Diseases; Biopsy, Needle; Combined Modality Therapy; Dipyridamole; Female; Glomerulonephritis; Humans; Immunosuppressive Agents; Methylprednisolone; Middle Aged; Neutrophils; Peroxidase; Plasmapheresis; Prednisolone; Ribonucleosides; Scleroderma, Systemic

1997
Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
    Nephron, 1998, Volume: 79, Issue:1

    Topics: Animals; B-Lymphocytes; Disease Models, Animal; Flow Cytometry; Glomerular Mesangium; Glomerulonephritis; Glomerulonephritis, IGA; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Proteinuria; Ribonucleosides

1998
[Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
    Nihon Jinzo Gakkai shi, 2000, Volume: 42, Issue:5

    Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Biomarkers; Combined Modality Therapy; Drug Therapy, Combination; Glomerulonephritis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Male; Methylprednisolone; Peroxidase; Plasma; Plasma Exchange; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Ribonucleosides; Treatment Outcome

2000
[Suppressive effect of mizoribine on progression of bovine serum albumin nephritis in mice].
    Nihon Jinzo Gakkai shi, 1987, Volume: 29, Issue:4

    Topics: Animals; Antibody Formation; Antigen-Antibody Complex; Disease Models, Animal; Female; Glomerulonephritis; Immunosuppressive Agents; Mice; Ribonucleosides; Serum Albumin, Bovine

1987